Company: TGNT
Filing Date: 2025-04-30
Form Type: S-1
Source: 0001477932-25-003124
Chunk: 15

Company: Totaligent, Inc.
Filing Date: 2025-04-30
Form: S-1
Chunk 15
---
 SEPA.

If and when we elect to issue and sell shares to the Selling Stockholder under the SEPA, we may need to register for resale under the Securities Act additional shares of our common stock in order to receive aggregate gross proceeds equal to the $3,000,000 available to us under the SEPA, depending on market prices for our common stock. If all of the 97,500,000 shares offered by the Selling Stockholder for resale under the registration statement of which this prospectus forms a part were issued and outstanding as of the date hereof (without taking into account the 4.99% Ownership Limitation), such shares would represent approximately 32.2% of the total number of shares of our common stock outstanding as of April 25, 2025 exclusive of the shares of Common Stock issuable pursuant to the conversion of our Series D Convertible Preferred Stock. If we elect to issue and sell more than the 97,500,000 shares offered under this prospectus to the Selling Stockholder, which we have the right, but not the obligation, to do, we must first register for resale under the Securities Act any such additional shares, which could cause substantial additional dilution to our stockholders. The number of shares ultimately offered for resale by the Selling Stockholder is dependent upon the number of shares we may elect to sell to the Selling Stockholder under the SEPA.

| 13 |

There are substantial risks to our stockholders as a result of the sale and issuance of common stock to the Selling Stockholder under the SEPA. These risks include the potential for substantial dilution and significant declines in our stock price. See the section entitled “Risk Factors-Risks Related to this Offering.” Issuances of our common stock in this offering will not affect the rights or privileges of our existing stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted as a result of any such issuance. Although the number of shares of common stock that our existing stockholders own will not decrease as a result of sales, if any, under the SEPA to the Selling Stockholder, the shares owned by our existing stockholders will represent a smaller percentage of our total outstanding shares after any such issuance to the Selling Stockholder.

The Selling Stockholder is wholly owned by Ben Hansel, a former Director of the Company.

Summary of Risk Factors

As an OTC Pink Market listed Company, we have limited resources with pressing capital requirements as we attempt to ramp up production. We are